Abstract
Knowledge of all drugs being prescribed for athletes on a team is very important for all members of the sports medicine team. Treatment of medical conditions, infections, pain, and trauma may require use of prescription medications. Many of these medications carry risk of side effects and interactions with other drugs as well as possible risk of dependency. It is important for the sports dentist to realize all of the risks and side effects of drugs prescribed as well as who else on the sports medicine team is a potential prescriber. Athletes may also get medications from friends and team mates or from the street to self- treat their conditions. Athletes also may seek out performance-enhancing drugs (PEDs) to assist them in achieving optimum performance in this highly competitive environment. This chapter will help the team dentist to be knowledgeable in these matters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alaranta A, Alaranta H, et al. Use of prescription drugs in athletes. Sports Med. 2008;38:449–63.
Burstein R, Hourvitz A, Epstein Y, Dvir Z, Moran D, Altar J, Shemer J, Shalev A, Galun E. The relationship between short-term antibiotic treatments and fatigue in healthy individuals. Eur J Appl Physiol Occup Physiol. 1993;66(4):372–5.
Schmid-Wendtner MH, Korting HC. Penciclovir cream—improved topical treatment for herpes simplex infections. Skin Pharmacol Physiol. 2004;17(5):214–8.
Tubridy E, Kelsberg G, et al. Which drugs are most effective for recurrent herpes labialis? J Fam Pract. 2014;63(2):104–5.
Opstelten W, Knuistingh A, et al. Treatment and prevention of herpes labialis. Can Fam Physician. 2008;54:1683–7.
Lee J, Kim JK, et al. Recovery time of platelet function after aspirin withdrawal. Curr Ther Res Clin Exp. 2014;76:26–31.
Cahill RA, McGreal GT, et al. Duration of increased bleeding tendency after cessation of aspirin therapy. J Am Coll Surg. 2005;200(4):564–73.
Cea Soriano L, Soriano-Gabarró M, GarcÃa RodrÃguez LA. Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use? Pharmacoepidemiol Drug Saf. 2015. https://doi.org/10.1002/pds.3926. [Epub ahead of print].
Anderson K, Hamm RL. Review article: Factors that impair wound healing. J Am Coll Clin Wound Spec. 2014;4(4):84–91.
Bailey S, Patrick O’Connor J. NSAID therapy effects on healing of bone, tendon, and the enthesis. J Appl Physiol. 2013;115(6):892–9. https://doi.org/10.1152/japplphysiol.00053.2013. Epub 2013 Jul 18.
Patrignani P, Tacconelli S, Bruno A, Sostres C, Lanas A. Managing the adverse effects of nonsteroidal anti- inflammatory drugs. Expert Rev Clin Pharmacol. 2011;4(5):605–21.
Moore PA, Hersh EV. Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions: translating clinical research to dental practice. J Am Dent Assoc. 2013;144(8):898–908.
Menhinick KA, Gutmann JL, et al. The efficacy of pain control following nonsurgical root canal treatment using ibuprofen or a combination of ibuprofen and acetaminophen in a randomized, double-blind, placebo-controlled study. Int Endod J. 2004;37(8):531–41.
Mehlisch DR, Aspley S, et al. Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: a randomized, double-blind, placebo-controlled, parallel- group, single-dose, two-center, modified factorial study. Clin Ther. 2010;32(5):882–95.
Mehlisch DR, Aspley S, et al. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double- blind, parallel-group, placebo-controlled, factorial study. Clin Ther. 2010;32(6):1033–49.
Cottler LB, Ben Abdallah A, et al. Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug Alcohol Depend. 2011;116(1-3):188–94.
McCabe SE, West BT, et al. Motives for medical misuse of prescription opioids among adolescents. J Pain. 2013;14(10):1208–16. https://doi.org/10.1016/j.jpain.2013.05.004. Epub 2013 Aug 15.
Pennsylvania guidelines on the use of opioids in dental practice. July 2015. proper reference format.
Denisco RC, Kenna GA, et al. Prevention of prescription opioid abuse: the role of the dentist. J Am Dent Assoc. 2011;142(7):800–10.
Diehl K, Thiel A, et al. Substance use among elite adolescent athletes: findings from the GOAL Study. Scand J Med Sci Sports. 2014;24:250–8.
Petróczi A, Aidman E. Psychological drivers in doping: the life-cycle model of performance enhancement. Subst Abuse Treat Prev Policy. 2008;3:7.
Terry-McElrath YM, O’Malley P, et al. Middle and high school drug testing and student illicit drug use: a national study 1998-2011. J Adolesc Health. 2013;52(6):707–15.
Castillo EM, Dawn Comstock R. Performance enhancing drugs prevalence of use of performance-enhancing substances among United States adolescents. Pediatr Clin. 2007;54(4):663–75.
Thevis M, Kuuranne T, et al. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal. 2016;8(1):7–29.
Momaya A, Fawal M, et al. Performance-enhancing substances in sports: a review of the literature. Sports Med. 2015;45(4):517–31.
Handelsman DJ. Performance enhancing hormone doping in sport. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. 2015. Source: Endotext. South Dartmouth: MDText.com; 2000.
Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38(4):644–51.
Sagoe D, Andreassen CS, et al. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abuse Treat Prev Policy. 2014;9:27.
DrugFacts: anabolic steroids. Rev July 2012. National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. http://www.steroidabuse.gov/.
Sci American. 2004;291(1).
Reardon CL, Creado S. Drug abuse in athletes. Subst Abuse Rehabil. 2014;(5):95–105.
Tandon S, Bowers LD, et al. Treating the elite athlete: anti-doping information for the health professional. Mo Med. 2015;112(2):122–8.
Kersey RD, Elliot DL. National Athletic Trainers’ Association position statement: anabolic-androgenic steroids. J Athl Train. 2012;47(5):567–88.
Zinder SM, Basler RS. National Athletic Trainers’ Association position statement: skin diseases. J Athl Train. 2010;45(4):411–28.
Books
Glick M, editor. Burket’s oral medicine, 12th ed. Raleigh: Peoples Medical Publishing House; 2015.
Malamed S. Handbook of local anesthesia. 6th ed. St. Louis: Elsevier Mosby; 2011.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rye, L. (2018). Athletic Performance: Drugs and Ergogenic Aids. In: Roettger, M. (eds) Modern Sports Dentistry. Textbooks in Contemporary Dentistry. Springer, Cham. https://doi.org/10.1007/978-3-319-44416-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-44416-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44414-7
Online ISBN: 978-3-319-44416-1
eBook Packages: MedicineMedicine (R0)